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HOST-MODULATING THERAPEUTIC APPROACHES IN PERIODONTAL 
DISEASE: HISTOLOGICAL EVALUATIONS 
 
BON JOON GOO 
 
 
ABSTRACT 
Periodontal disease is an oral inflammatory disease often associated with damage 
to the soft tissues and hard structures that support teeth. Within the subgingival biofilm, 
multiple microorganisms initiate inflammatory responses that can lead to a chronic oral 
inflammatory state, in which periodontal ligament may be damaged leading to alveolar 
bone loss. In recent studies, amnion-derived cellular cytokine solution (ACCS) and 
cytokines secreted by the amnion-derived multipotent progenitor cells (AMPs) obtained 
from the placenta illustrated evidence of wound healing, promotion of macrophage 
activity, and infected tissue repair. Furthermore, ACCS were capable of preventing 
periodontal inflammation induced by Porphyromonas gingivalis (P. gingivalis) in an 
experimental model, suggesting its role in modulating host’s inflammatory response in 
order to arrest, if not eradicate, inflammation in periodontal tissues.. This study aimed to 
investigate a novel combination of ACCS that specifically targeted the bone tissues. 
Whereas in previous study, ACCS was tested to identify the efficacy of its ability to 
reduce inflammation and to repair damages in gingiva and reduce alveolar bone loss, 
ACCS-B was tested here to determine its impact on bone turnover. 
The study used a periodontal model of rabbit jaws to induce periodontitis. 
Periodontitis-specific pathogen P. gingivalis was applied in a carboxymethyl cellulose 
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(CMC) slurry topically applied to the mandibular second premolars at the site of silk 
ligatures.. The silk ligatures were placed to serve as the retention for the P. gingivalis 
slurry. The protocol followed two phases, the disease induction phase (6 weeks) and the 
treatment phase (6 weeks). In the disease induction phase, 24 New-Zealand White rabbits 
were induced with topical P. gingivalis every other day on the mandibular premolars. At 
the end of this phase, 3 rabbits were randomly selected and sacrificed to serve as the 
baseline disease group.  Of the remaining 21 rabbits, 3 rabbits were kept untreated and 
served as untreated-control group and the remaining 18 rabbits were randomly assigned 
to 3 different treatment groups: Placebo Treatment (Saline), ACCS-U treatment, and 
ACCS-B treatment.  During the treatment phase, each treatment group received its 
respective treatments to the ligated sites 3 times a week in an every-other-day fashion. 
After 6 weeks, the rabbit jaws were evaluated histologically.  
At the end of treatment phase, the untreated group exhibited significant 
progression of periodontal disease evident by the destruction of soft and hard tissue on 
the site of interest. ACCS-U and ACCS-B showed substantial reduction of tissue 
inflammation and crestal bone loss compared to those in baseline disease, untreated, and 
saline-treated groups, however there were no statistically significant differences between 
ACCS-B and ACCS-Utreated sites. . Histological findings, specifically Masson’s 
Trichrome stained sections, revealed that collagen deposition and new bone formations 
were actively present in the alveolar bone of ACCS-treated groups. Moreover, 
quantitative assessments of inflammatory cell activity and osteoclastic activity at the 
crestal and along the bone surfaces of the ligated sites by Hematoxylin-Eosin stains and 
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tartrate-resistant acid phosphatase stains respectively, confirmed the anti-inflammatory 
activity by the ACCS-treatments. The osteocalcin stained cells also revealed the initiation 
of bone formation and bone repair in the ACCS-treated groups. 
These results state a clear indication of control of inflammatory disease and as a 
result, bone formation and tissue repair in both ACC-U and ACC-B treated groups.. As 
for the untreated group and the baseline disease group, significant disease progression is 
highlighted by bone loss and high level of inflammation in the site of interest. Although 
ACCS-B was inferior to previously tested ACCS-U with regard to anti-inflammatory 
effects and bone formation it clearly demonstrated its future use as potential treatment for 
periodontal disease, along with restoration of damaged tissues. These results further 
solidify findings that ACCS acts through host-modulated anti-inflammatory actions in the 
inflammatory conditions. 
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INTRODUCTION 
 
 Periodontal disease is defined as a chronic inflammatory condition that leads to 
the destruction of the supporting structures of the teeth (Laudenbach & Simon, 2014). It 
is understood that as periodontal disease progresses, connective tissue, periodontal 
ligament and alveolar bone are at risk of destruction, tissue damage, which can ultimately 
lead to tooth loss.. While it is evident that the etiology of periodontal diseases is defined 
by multiple species of bacteria residing in the oral cavity, it is important to note that the 
greater cause of damaging both the soft and the hard tissues of the gingiva and alveolar 
bone is the inflammatory response that the host modulates (Genco, 1992). Past few 
decades of research and effort were spent solely on anti-bacteria and anti-infective 
therapies given the distinct etiology of this disease. However, recent studies illustrate that 
the subgingival environmental changes, due to the presence of oral bacteria, are the result 
of host-modulated inflammatory response (Bartold et al., 2013). Thus greater emphasis 
now rests on the search to effectively alleviate, if not fully control, the host’s response.  
The progression of periodontal disease can be detected by measuring the depth of 
the periodontal pockets around the affected teeth.. Increase in the amount of plaque and 
the pathogenic microorganisms that secrete toxins in turn irritates the periodontal tissues 
and stimulates inflammatory response. As teeth and bone structures break down by the 
process, gingival tissues are separated from the teeth forming pockets.  The extension of 
inflammation leads to the pathologic deepening of the gingival sulcus (Reddy, 2008). A 
sulcus depth beyond 3 mm is considered gingivitis and increasing pocket depth and 
attachment loss mark the transition into periodontitis (Figure 1). 
	  2 
 
 
Epidemiology of Periodontal Disease 
 
 According to the data from the National Health and Nutrition Examination Survey 
(NHANES), it was estimated that 46% of United States adults, which represents 64.7 
million people in its category, suffer from periodontitis and of those 64.7 million people, 
8.9% are in advance periodontitis stage. Overall this disease prevalence was positively 
associated with males and increasing age (Eke et al., 2015). Treatments may include 
barrier membranes, graft materials, and application of bioactive molecules, however, 
their effects are modest at best (Hughes et al., 2010). Despite the long history and the 
awareness of periodontal disease, a treatment method enabling the health of patient’s oral 
cavity to return to its nourishing environment still remains to be seen. As statistics from 
NHANES indicate, periodontal disease becomes a burden to many patients and especially 
to those over 30 years old, primarily due to multiple implications that the disease may 
inflict on patients’ health. Recent studies show strong bidirectional relationship between 
 
Figure 1: Progression of Periodontal Disease 
(http://eicondental.com/services/periodontal-disease/) 
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diabetes and periodontal disease, rheumatoid arthritis and cardiovascular disease. Data 
also shows strong associations between periodontal disease and oral cancer (Bascones-
Martínez et al., 2014; Yao et al., 2014). Furthermore, the inflammatory cytokines, host’s 
response to bacteria, can be elevated in the systemic circulation and induce disruption of 
protein levels in the liver namely, CRP, fibrinogen and serum amyloid A, that promote 
atherosclerosis, and may also cause adverse pregnancy outcomes (Figure 2) 
(Hajishengallis, 2014). These findings, along with bidirectional relationships above, 
illustrate the importance of controlling, maintaining, and treating periodontal disease. 
Periodontal disease affects millions of patients globally and still lacks a fundamental 
treatment, thereby significantly raising its need for research in this field.  
 
      
Figure 2: Biologically plausible mechanisms linking periodontitis to 
systemic inflammation and disease. 
(http://www.nature.com/nri/journal/v15/n1/fig_tab/nri3785_F3.html)	  
	  4 
Etiology of Periodontal Disease 
It is well established that dental bacterial plaque plays a crucial role in both 
gingivitis and periodontitis. Whereas the former precedes periodontitis and is a reversible 
inflammatory reaction, the latter is irreversible in that the soft tissues and the alveolar 
bone itself are damaged. The accumulation of dental bacteria plaque is necessary for 
periodontal disease to develop, however periodontitis requires the susceptibility of the 
host’s inflammatory system to fully develop (Tatakis et al., 2005).  
Dental bacteria plaque follows several phases of different formation, but it 
ultimately results in a condition known as biofilm. At the gingival margin, the microbial 
biofilm is formed in order to epitomize the development and growth of bacteria’s colony 
(Pöllänen et al., 2013). The biofilm increases its mass through a process known as auto-
aggregation, where same species are attracted to each other, and also through co-
aggregation, where different species are attracted (Kolenbrander, 2000). Multispecies 
biofilms then contribute to local inflammation in periodontium by elevating levels of IL-
1α, IL-6 and other various pro-inflammatory and chemokines (Peyyala et al., 2013). 
Biofilm is a complex, organized, living system specifically designed to protect itself and 
grow exponentially.  
Despite such complex structure being difficult to analyze, studies show that 
biofilm achieves its goals through cell-cell communication, gene transfer, antimicrobial 
resistance, gene expression regulation, lipopolysaccharide membrane, presence of heat 
shock proteins and extracellular proteolytic enzymes (Tatakis et al., 2005). One 
promising approach to intervene in the formation of microbial multi-biofilms is through 
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inhibition of adhesion between conglomerated mass of bacterial colony, thus impeding 
the interactions and recruitment of other bacterial species (Demuyser et al., 2014). 
Each periodontal disease has a unique profile of bacteria that is associated with 
them. This statement is aligned with the fact that different bacteria have their distinctive 
characteristic in both the causation and progression of the disease (Tatakis et al., 2005). 
All bacteria are in some extent involved with different periodontal diseases due to the 
nature of oral cavity but, studies have shown some of the more recognized species 
involved with specific periodontal disease (Table 1). 
 
Table 1. Bacterial species associated with periodontal health and disease. 
Data taken from Tatakis et al., 2005. 
 
 
Condition 
 
Associated  Microorganisms 
 
Periodontal Health Gram (+) anaerobe 
   Atopobium rimae 
Gram (+) facultative 
   Streptococus sanguis 
   Streptococous mitis 
Gram (-) anaerobe 
   Bacteroiedes sp oral clone BU063 
   Veillonella spp 
   Gemella spp 
   Capnocytophaga spp 
Gingivitis Gram (+) anaerobe 
   Actinomyces sanguis 
   Peptostreptococcus micros 
Gram (+) facultative 
   Streptococus spp 
Gram (-) anaerobe 
   Campylobacter gracilis 
   Fusobacterium nucleatum 
   Prevotella intermedia 
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   Veillonella parvula 
Chronic Periodontitis Gram (+) anaerobe 
   Peptostreptococcus micros 
Gram (-) anaerobe 
   Porphyromonas gingivalis 
   Tannerella forsythia 
   Campylobacter rectus 
   Eikenella corrodens 
   Fusobacterium nucleatum 
   Actinobacillus 
      Actinomycetemcomitans 
   Treponema spp 
   Filifactor alocis 
   Megasphaera sp oral clone BB166 
   Deferribacteres sp oral clone BH017 
   Desulfobulbus sp oral clone R004 
   Bacteroides sp oral clone AU 126 
Aggressive 
Periodontitis 
Gram (-) anaerobe 
    Actinobacillus 
      Actinomycetemcomitans 
   Porphyromonas gingivalis 
   Campylobacter rectus 
   Eikenella corrodens 
Acute Necrotizing 
Gingivitis 
Gram (-) anaerobe 
   Treponema spp  
   Prevotella intermedia 
   Rothia dentocariosa 
   Fusobacterium spp 
   Achromobacter spp 
   Propionibacterium acnes 
   Capnocytophaga spp 
Periodontal Abscess Gram (+) anaerobe 
   Peptostreptococcus micros 
Gram (-) anaerobe 
   Fusobacterium nucleatum          
   Prevotella intermedia 
   Tannerella forsythia 
   Campylobacter rectus 
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Rationale for Animal Models  
Researchers have always addressed the importance of animal models, despite 
their limitations. Different animal models are essential for testing diverse biological 
significances that otherwise will be left to question. Recent studies have shown that 
animal-based studies provide framework in which mechanisms of periodontitis can be 
studied and clarified (Struillou et al., 2010). Moreover, these studies illustrate that 
dysbiosis, rather than individual bacteria species, is etiologically significant for initiating 
host inflammatory response that results in periodontal bone loss and soft tissue damage. 
However, the most noteworthy intake from these studies is how animal models contribute 
to the testing of possible therapeutic targets (Hajishengallis et al., 2015). While 
experiments conducted through animal models may not be directly applicable to humans, 
they have proven to be of a vital use, often replacing in vitro experiments (Oz et al., 
2011). In addition, there is no animal model where all aspects of human life and disease 
are directly correlated, due to the complex nature of human body.. For example, Salk was 
able to successfully create a vaccine against strains of polio through Rhesus monkey 
cross-contamination studies (Shampo & Kyle, 1998). Specific animal models, thus, 
provide insight to particular disease mechanism that otherwise would be difficult to 
identify.   
 
 Rabbit models are ideal for studying periodontal disease and its association with 
host inflammatory response. Because of their size, easy handling, short life span, and 
economical aspects in purchasing and sustaining, rabbits are a first-hand choice in 
regards to sampling and sustaining in a lab environment (Stübinger et al., 2013). In 
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addition to handling, rabbits are perfect in that previous work have succeeded in inducing 
controllable and reproducible periodontitis through application of specific species of 
bacteria, P gingivalis, and silk ligatures (Hasturk et al, 2006, 2007, Zenobia et al., 2014). 
Furthermore, rabbit models are constantly being used due to their simplicity as mentioned 
above, its similarity to human systems and lastly their response to certain irritants. Hence, 
rabbit models have been used for other inflammatory diseases and other human diseases 
as a consequence; atherosclerosis (Fan et al., 2015), implant dentistry and related tissue 
regeneration (Stübinger et al., 2013), lung disease and stem cell therapy (Kamaruzaman 
et al., 2013), and pathophysiology of rhinosinusitis (Perez et al., 2014). Therefore due to 
their straightforwardness and resemblance to human response, rabbits are an ideal model 
to study mechanisms involving periodontal tissue regeneration and alveolar bone gain 
and repair.  
 
Application of ACCS 
Successfully inducing controlled and reproducible periodontitis in rabbits may 
shed light on the mechanisms surrounding the host’s inflammatory response towards 
infection; however, it does not present a therapeutic treatment. Hence, identifying the 
best therapeutic solution to not only alleviate host’s inflammatory action, but also to 
chronic wound healing in the subgingival ligament and alveolar bone regeneration is 
necessary to eradicate periodontal disease. Amnion-derived multipotent progenitor cells 
(AMPs) secrete cytokines known as amnion-derived cellular cytokine solution (ACCS). 
AMPs are acquired from the placenta and despite it being a stem cell it is non-
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tumorigenic and non-immunogenic (Banas et al., 2008). Moreover, human amnion-
derived cells are more reliable, in that they are less likely to contain genetic aberrations 
and can be programmed earlier for more efficiency, characteristics that the multipotent 
stem cells did not exhibit (Saito et al., 2012). Moreover, the secreted ACCS contain 
cytokines vital for acute and chronic wound healing (Franz et al., 2008), promote 
migration of macrophages into the wound-site (Uberti et al., 2011), arthritis (Tramontini 
et al, 2004), and finally, have substantial anti-inflammatory and anti-fibrotic properties 
(Silini et al., 2013).  
ACCS contain proteins such as platelet-derived growth factor (PDGF), vascular 
endothelial growth factor (VEGF), angiogenin, and transforming growth factor beta 2 
(TGF-β2) and they provide pathways eventually contributing to wound healing (Steed et 
al., 2008). In addition to providing these proteins, ACCS also play a role in controlling 
keratinocyte and fibroblast migration to further enhance wound healing in different parts 
of the body (Uberti et al., 2010). Recent studies show that ACCS was not only capable of 
preventing periodontitis in experimental model, but also able to repair damaged tissues 
and alveolar bone suggesting its role in reversing the severity of inflammation response 
initiated by the host (Hasturk et al., 2013). 
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SPECIFIC AIMS 
 
 The primary aim of this present study was to examine the effectiveness of a novel 
formulation of ACCS compared to the formulation previously tested for periodontal 
tissue regeneration (Hasturk et al., 2013).  The previous study used original ACCS-U 
whereas in this study, a new formulation of ACCS designed to target the bone tissue, 
ACCS-B, was tested for therapeutic purposes. This study used a model of inducing 
periodontitis in rabbit premolars by placing silk ligatures and topical application of 
specific bacterial species, P. gingivalis. After two phases each lasting 6 weeks, 
histological analysis was performed to evaluate the efficacy of the new ACCS-B 
formulation.    
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METHODS 
 
Animal Model 
In phase 1, disease induction, periodontal disease was induced in 24 adult (3 
months old) male New Zealand White rabbits. At the end of the phase 1, the pathogenic 
microorganism, P. gingivalis, application was halted and 3 rabbits were randomly 
selected and subsequently sacrificed to serve as a baseline disease group. The baseline 
disease group is established to compare the results in the phase 2, the treatment phase. 
The remaining 21 rabbits are randomly assigned into 3 groups of 6, each group 
representing test group, positive control group, and negative control group. The last 3 
rabbits are assigned into untreated group. The 3 groups aforementioned are entered into 
phase 2 lasting 6 weeks of two different amnion-derived cellular cytokine solutions and 
placebo (saline). 
 
Phase 1: Disease Induction 
The protocol was reviewed and approved by the Forsyth Institute Institutional 
Animal Care and Use Committee (Forsyth IACUC) prior to study. Specific pathogen-free 
NZW rabbits were purchased from Covance Research Products, Inc. (Denver, PA), 
equilibrated for 7 days prior to experiments and housed for the duration of the study at 
the rabbit facility at the Forsyth Institute (1st Floor Rabbit Facility-Holding Room 2).  
Experimental periodontitis were induced using previously published methodology for 
rabbit periodontitis model (Serhan at al 2003; Hasturk et al, 2006, 2007, 2009).  Briefly, 
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on the day of experiment, the rabbits were anesthetized using xylazine (5 mg/kg, IM) and 
ketamine (35 mg/kg, IM). A ligature (3-0 braided silk suture) was placed around the 2nd 
premolars of both sides of the mandible followed by P. gingivalis slurry application (as 
described below). After baseline ligature placement, animals were anesthetized using 
inhalation anesthesia (isoflurane; 3-4% for induction of sedation in induction box; 2.5% 
for continuation of sedation for oral applications) every other day (Monday, Wednesday 
and, Friday) to receive CMC slurry (1 ml) containing P. gingivalis for the first 6 weeks. 
At these times, the sutures were checked, and lost or loose sutures were replaced (at 
average once or twice for the total period). (Figure 3). All experimental procedures were 
conducted in the procedure room dedicated for the rabbit experiments (1st floor Rabbit 
Facility). 
P. gingivalis (strain A7436; Shapira et al, 1998) was grown using standard 
procedures (Olsen and Socransky, 1981; Doan et al, 1999; Socransky et al, 1994).  
Briefly, bacteria were cultured on agar plates containing trypticase soy agar 
supplemented with 0.5% (w/v) yeast extract (Gibco Industries, Los Angeles, CA), 5% 
defibrinated sheep red blood cells, 5 µg hemin, and 1 µg/ml vitamin K (Sigma-Aldrich, 
St. Louis, MO).  Plates were incubated for 3 days at 37°C in an anaerobic chamber 
maintained by hydrogen gas mixture (hydrogen/nitrogen) that is circulated through a 
heated palladium catalyst. Colonies were randomly selected and anaerobically cultured 
overnight at 37°C in Wilkins-Chalgren Anaerobe Broth. Colonies were randomly 
selected and anaerobically cultured overnight at 37°C in growth medium (Schaedler’s 
broth) supplemented with vitamin K and hemin. Bacterial numbers were 
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spectrophotometrically determined at 600 nm and 109 colony-forming units (CFU) (0.8 
OD) in growth medium (1 ml) and mixed with carboxymethylcellulose (CMC) to form a 
thick slurry, which was applied topically to the ligated teeth to induce periodontitis for 6 
weeks.  
Phase 2. Treatment 
At the end of Phase 1, 3 rabbits were sacrificed to form the baseline disease group 
(Reference group) at 6 weeks. The remaining 21 rabbits randomly assigned into 4 groups 
entered in Phase 2 for a period of six weeks: 3 treatment groups as well as an untreated 
control group as shown below: 
Study groups: 
1. Test (ACCS-B) treatment group (n=6) 
2. Positive control (ACCS-U) treatment group (n=6)  
3. Placebo/Sham (Saline) treatment group (n=6) 
4. Untreated (Control) group (n=3) 
5. Reference (baseline periodontal disease at 6 weeks) group (n=3) 
P. gingivalis application has ceased from this point on, but the ligatures were kept for 
topical applications. Test and placebo products were topically administered every-other-
day (Mon-Wed-Fri) in 10 microliters/tooth/animal (in total 20 microliters per rabbit) 
using a blunt tipped 10 µL Hamilton syringe (Model 1701 Gastight Point Style 3-Cat# 
14-813-125;Fischer Scientific) to the ligated sites, on the gum line, for 6 weeks. During 
this period lost sutures were replaced, if lost (once or twice per rabbit) (Figure 3).  
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Figure 3. Timeline of experimental design.  
 
Phase 1: 3-0 silk ligatures were tied to second premolars in mandibular quadrants at 
baseline in all groups and P. gingivalis was applied in methylcellulose slurry via a 3 ml 
plastic syringe without needle three times per week (M-W-F) for six weeks. At six 
weeks, 3 animals were sacrificed and the extent of disease determined as baseline 
periodontitis (represented by red bar in the following figures).  
 
Phase 2: P. gingivalis application was ceased at this point and the other animals 
continued for a second six-week with treatment: 1) ACCS-B, 2) ACCS-U, and 3) Saline 
(6 rabbits/group).  An additional group of 3 rabbits were kept untreated and served as 
negative control. All treatment solutions were topically delivered to the ligated site at the 
gum line via a blunt tipped 10µL Hamilton syringe. All treatment/untreated groups were 
sacrificed at 12 weeks and the extent of disease determined for comparison to baseline 
periodontitis and health (historical data). 
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Tissue Analysis 
 For histological analysis, the other half of the mandible was immersed in a 
volume of 10% EDTA solution equal to at least 20 times the size of section; solution was 
replaced every 2-3 days for 8 weeks while continuous gentle shaking was provided for 
stimulation of the process (Skinner et al 1997). X-rays determined the end point of the 
decalcification. After decalcification, specimens were dehydrated using xylene and 
embedded in paraffin. Thin sections (5 µm) were cut and sections were either 
conventionally stained with hematoxylin-eosin (H&E) to identify the cellular 
composition of the inflammatory infiltrates or with tartrate-resistant acid phosphatase 
(TRAP) to detect the osteoclastic activity. Some sections from each specimen were also 
stained with Masson’s Trichrome for collagen deposition and new bone formation.  
Lastly, to compliment the findings with osteoclastic activity, immunohistochemistry 
staining was performed for detection of osteocalcin positive cells. 
The cellular infiltrate was quantified using a method originally developed in our 
laboratories (Uzel et al, 2001) to assess the density of the inflammatory cells. Leukocytes 
were counted and the results presented as cells/unit area mm2. This measurement was 
performed using a standard area under the microscope (0.09mm2); repeated for 3 
different slides for each specimen, and expressed as the average of 3 slides to assess the 
extent of inflammatory infiltrate. 
To evaluate the osteoclastic activity (osteoclastogenesis) during inflammatory 
changes in the periodontal tissues, osteoclast-like cells were identified using tartrate 
resistant acid phosphatase (TRAP) staining. TRAP-positive cells were counted in the 
-­‐-­‐-­‐-­‐-­‐-­‐Phase	  1-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐
-­‐-­‐-­‐-­‐	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coronal 1/3 of the root on each section (cells/mm2) using Image J software program and 
calculated for both mesial and distal crestal alveolar bone of the ligated tooth (second 
premolar).  
To evaluate the osteoblastic activity or bone formation activity, osteocalcin 
positive cells were detected by anti-osteocalcin antibody (OC4-30) (Abcam®; Catalog 
No: ab13418) using immunohistochemistry (IHC) technique for paraffin embedded 
sections.  Similarly, osteocalcin- positive cells were counted in the coronal 1/3 of the root 
on each section (cells/mm2) using Image J software program and calculated for both 
mesial and distal crestal alveolar bone of the ligated tooth (second premolar). 
Collagen fibers at the supracrestal areas and between tooth and bone were 
evaluated on Masson’s trichrome stained sections. Specifically, the collagen deposition 
and the organization of collagen fibers were evaluated.  
In order to quantify the changes in bone, the mean value (± standard deviation) of 
the linear distance for bone loss were calculated for each group. Previously developed 
measurement technique (Hasturk et al, 2006) was used to calculate the bone changes at 
three different sections of the root using the image analysis software (Image J). The linear 
measurements were made at three levels each corresponding to one-third of the root and 
alveolar bone interface: crestal, mid, and apical. Linear distance is reported as the 
distance from the base of the epithelium to the alveolar crest border at the three chosen 
levels, the apical, middle, and the coronal third of the root and is expressed as the 
difference between ligated and non-ligated sites. Results were presented at the crestal and 
mid-level (Figure 2).  
	  17 
Data Analysis 
In this study, we investigated the potential effects of the ACCS-B solution in 
periodontal tissue regeneration compared to ACCS original, placebo and control 
(untreated).  Based on our previous study with ACCS original (Hasturk et al,2013)), for 
intrabony defect changes, the mean difference between the ACCS original and ACCS 
irradiated was 0.4 mm with a standard deviation of 0.4. Hence, assuming mean difference 
of 0.4 mm with SD of 0.4 and alpha=0.05, and 80% power, a sample size of 6 per group 
for the test groups (ACCS-B, ACCS original and placebo) was sufficient.   Due to large 
differences between the test groups and both baseline disease and untreated groups, the 
animals’ numbers were reduced to 3 rabbits each.  In addition, we used our previously 
generated data (historical) to increase the sample size in these groups, if needed. 
The data obtained by direct measurements during morphologic assessment and by 
histomorphometric measurements were used in multiple statistical analyses. Mean values 
for linear and area measurements were utilized to determine the changes in bone level in 
reference disease group compared to treatment groups at 12 weeks. The ratio calculations 
were also used and multiple comparisons within groups were made using analysis of 
variance (ANOVA) with post hoc tests Bonferroni or LSD correction. 
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RESULTS 
Histological Analysis 
 
As illustrated in Figure 4, the histological analyses were performed on paraffin-
embedded decalcified hemi-mandibles. Thin sections (5µm) were taken from each 
specimen-paraffin block (up to 30 sections). Consecutive sections at the middle of the 
block were stained with:  
• Hematoxylin and eosin (H&E) for descriptive analysis of characteristics of the 
tissue, quantification of inflammatory cell infiltrate and histomorphometric 
assessments for alveolar bone levels. 
• Tartrate acid phosphatase (TRAP) for the determination of osteoclastic cell 
activity (osteoclastogenesis). 
• Masson’s trichrome for the determination of collagen activity ad collagen fibers at 
the supracrestal level of the dento-alveolar unit. 
• Osteocalcin for the analysis of osteoblastic cell activity at the ligated sites 
  
	  19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histologic assessments of the sections from each group were performed under 
light microscope at 25X, 100X, 200X and 400X magnifications for the details of tissue 
characteristics. As reported previously (Hasturk et al 2007, 2009), every-other-day 
topical P. gingivalis slurry application at the ligated sites of mandible resulted in 
experimental periodontitis induction during the first 6 weeks of the experiment indicated 
by inflammatory changes at both soft tissue and alveolar bone levels.  Soft tissue 
exhibited typical characteristics of periodontal pocket formation with increased 
inflammatory cell infiltration.  (Figure 5A).  
Figure 4. Schematic illustration of histomorphometric measurements.  
5 µm paraffin-embedded sections stained with H&E staining were used for 
histometric analysis. Three measurements were made for each area (crestal, middle 
and apical) and averages are taken for each representative site (NL-non-ligated; L-
ligated).   
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In the second phase of the study, the P. gingivalis applications were stopped and 
in the untreated group, the progression of disease was assessed.  The analyses of sections 
from the untreated specimens showed significant inflammatory cell infiltration in 
connective tissue and bone resorption, with irregular bone surfaces and resorptive lacunae 
at the ligated sites (Figure 5B).  The treated groups with ACCS-U and ACCS-B however 
showed significantly less inflammatory changes with an intact bone surface and a healthy 
connective tissue; the inflammatory changes and bone loss were clearly diminished in 
these groups (Figure 5D and E, respectively). Saline treatment did not result in any 
significant changes in tissue inflammation or bone loss (Figure 5C) from baseline; the 
group exhibited more inflammatory changes and bone loss indicating disease 
progression. 
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Figure 5. Histological Evaluations.  
A. Baseline disease shows characteristics of inflammatory changes in connective tissue 
and crestal bone loss.  
B. When the baseline disease left untreated, the progression of inflammation and bone 
loss were apparent. The inflammatory cell infiltration was dense, bone loss was detected 
with resorptive lacunae at the crestal and interproximal sites.   
C. Saline treatment did not affect the disease process; the inflammatory cell infiltration 
was quite obvious as well as the alveolar bone loss at both crestal and interproximal 
sites. 
 D and E. ACCS-U and ACCS-B treatment groups exhibited the least inflammatory 
changes and bone loss at the ligated sites (Images shown-H&E 25x and 100x 
magnifications; red arrow depicts the inflammatory cell infiltration at the disease-ligated 
site).   
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Tables 2-4 show multiple comparisons between groups with regard to histological 
bone loss/gain, the counts of inflammatory cell, TRAP+ cell and osteocalcin + cell at 
crest and middle portion of the alveolar bone. Histomorphometric measurements showed 
similar findings as clinical evaluations; ACCS treated tissues demonstrated significantly 
less bone loss, less inflammation in soft tissue and less osteoclastogenic activity 
compared to untreated and placebo groups confirming the potential impact of ACCS-U 
on the treatment of periodontal diseases. The tested compound, ACCS-B demonstrated 
comparable results to ACCS-U in histological assessments of periodontal tissues with 
significant reduction in periodontal inflammation and breakdown of alveolar bone and 
periodontal tissues (Figures 6-8).  Masson’s Trichrome staining also showed more 
collagen deposition and well organized collagen fiber orientations at the supracrestal 
level in the ACCS-treated specimens compared to baseline disease, untreated and saline-
treated groups (Figure 9). Osteoblastic activity was also evaluated by immunohisto-
chemistry in sections stained with osteocalcin as a marker of new bone formation (Table 
5, Figure 10). ACCS-treated groups exhibited greater osteoblastic activity along the 
alveolar bone (both crestal and interproximal at the ligated sites) compared to other 
groups (baseline, untreated and saline treated). 
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Table 2. Multiple comparisons for histological bone loss between groups 
The data obtained by direct measurements during morphologic assessment and by 
histomorphometric measurements were used in multiple statistical analyses. Mean values 
for linear and area measurements were utilized to determine the changes in bone level in 
reference disease group compared to treatment groups at 12 weeks. The ratio calculations 
were also used and multiple comparisons within groups were made using analysis of 
variance (ANOVA) with post hoc tests Bonferroni or LSD correction. 
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Table 2. continued. Multiple comparisons for histological bone loss between groups 
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Figure 6. Histomorphometric bone level.  
Linear distance was measured as the distance from the base of the epithelium to the 
alveolar crest border at the three chosen levels, the apical, middle, and the coronal third 
of the root and is expressed as the difference between ligated and non-ligated sites. 
Results were presented at the crestal and mid-level as described elsewhere (Figure 4). 
Similar to clinical findings P. gingivalis application resulted in significant bone loss 
compared to ligature alone group (historical data) at both crestal and mid-level of the 
alveolar bone confirming the disease model used in this study (p=0.002 and p=0.028, 
respectively).  The untreated and saline treated groups showed typical characteristics of 
the disease, progression of bone loss, at crestal level compared to baseline disease; 
however the difference was not statistically significant. While both groups showed 
statistically significant bone loss compared to ligature alone group (p=0.02 and p=0.03, 
respectively).  Both ACCS-treated groups dramatically reduced the histological bone loss 
indicating bone gain at crestal level compared to all other disease groups (p<0.001); 
ACCS-U treatment also showed significant bone gain at mid-level compared to baseline 
and untreated groups (p=0.05 and p=0.008, respectively), while both saline and ACCS-B 
treatment resulted in more bone at mid-level compared to baseline disease (p=0.41 and 
p=0.01, respectively).  *Statistically significant bone loss compared to ligature alone and 
ACCS groups (p<0.05); #Statistically significant bone loss compared to baseline disease 
group (p<0.05); ‡Statistically significant compared to baseline, untreated and saline 
groups; †Statistically significant compared to baseline and untreated groups (ANOVA, 
LSD post hoc test; p<0.05). 
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Table 3. Multiple comparisons for inflammatory cell infiltration between groups 
Thin sections (5 µm) were cut and sections were either conventionally stained with 
hematoxylin-eosin (H&E) to identify the cellular composition of the inflammatory 
infiltrates. The ratio calculations were also used and multiple comparisons within groups 
were made using analysis of variance (ANOVA) with post hoc tests Bonferroni or LSD 
correction 
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Figure 7. Inflammatory cell infiltrate.  
Inflammatory infiltrate was quantified by cell counting per unit area (0.09 mm2) at 
supracrestal and interproximal surfaces at the ligated sites (3 sections per specimen). 
Baseline, untreated and saline groups showed significantly more inflammatory cell 
counts compared to ACCS-U treated groups.  Although ACCS-U treatment resulted in 
the least counts compared to ACCS-B treated group the difference was not statistically 
significant. *Statistically significant reduction in inflammatory cell infiltration compared 
to untreated and saline groups. †Statistically significant reduction in inflammatory cell 
infiltration compared to baseline and untreated groups (Mean ±SD; p<0.05; ANOVA and 
LSD post hoc test). (Images shown- H&E, 200X). 
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Table 4. Multiple comparisons for osteoclastic activity (TRAP+ cell counts) between 
groups 
The osteoclast-like cells were identified using tartrate resistant acid phosphatase (TRAP) 
staining. TRAP-positive cells were counted in the coronal 1/3 of the root on each section 
(cells/mm2) using Image J software program and calculated for both mesial and distal 
crestal alveolar bone of the ligated tooth (second premolar). The ratio calculations were 
also used and multiple comparisons within groups were made using analysis of variance 
(ANOVA) with post hoc tests Bonferroni or LSD correction. 
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Figure 8. Osteoclastogenesis.  
TRAP + cells were counted using Image J software program at crestal and middle 
portions of the alveolar bone using a standard area (0.09 mm2) for each site (first and 
second premolar ligated sites), three sections/specimen. The results are shown as the 
average of two sites and total area of crestal and middle portions of each site. ACCS 
treated groups showed fewer osteoclasts around alveolar bone and the difference between 
all other groups was statistically significant confirming the histological findings with 
inflammatory cells and bone loss. ACCS-B resulted in reduced number of osteoclastic 
activity similar to ACCS-U group with no statistical difference. All other disease groups 
including baseline, untreated and saline-treated groups demonstrated elevated number of 
osteoclasts residing in the lacunas of alveolar crest and interproximal areas, *Statistically 
significant reduction in osteoclast counts compared to baseline disease, untreated and 
saline-treated groups (Mean ±SD; p<0.05; ANOVA and LSD post hoc test). (Images 
shown- TRAP, 400X). 
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Figure 9. Evaluation of collagen deposition.  
Collagen depositions around alveolar crest and interproximal areas were evaluated by 
Masson’s trichrome staining (collagen fibers: blue; new bone deposition: red). Baseline 
disease and untreated groups as well as saline-treated group showed destruction in the 
collagen fibers at the crestal and interproximal areas. Conversely, the ACCS-treated 
groups showed dense and well organized collagen fibers at the supracrestal and 
interproximal area (depicted by red arrow). ACCS-B treated site showed activity of new 
bone formation with new collagen fiber deposition at the crestal site confirming the 
clinical findings (depicted by red arrow). (Images shown-Masson’s Trichrome, 400X). 
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Table 5. Multiple comparisons for osteoblast-like cell (Osteocalcin+ cells) counts    
between groups 
The osteocalcin- positive cells were counted in the coronal 1/3 of the root on each section 
(cells/mm2) using Image J software program and calculated for both mesial and distal 
crestal alveolar bone of the ligated tooth (second premolar). The ratio calculations were 
also used and multiple comparisons within groups were made using analysis of variance 
(ANOVA) with post hoc tests Bonferroni or LSD correction. 
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Figure 10. Osteoblastic activity.  
Osteocalcin + cells were counted using Image J software program at crestal and middle 
portions of the alveolar bone using a standard area (0.09 mm2) for each site (first and 
second premolar ligated sites), three sections/specimen. The results are shown as the 
average of two sites and total area of crestal and middle portions of each site. ACCS 
treated groups showed a statistically significant osteoblastic activity confirming the bone 
repair and formation seen in clinical and histological assessments compared to baseline, 
untreated and saline groups (p=0.0001).  *Statistically significant compared to baseline 
disease, untreated and saline-treated groups (Mean ±SD; p<0.001; ANOVA and LSD 
post hoc test). (Images shown- Osteocalcin, 400X). 
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 DISCUSSION 
 
 This study clearly demonstrates the role of ACCS in its application for the 
treatment of periodontal disease and restoration of damaged tissues. In addition, although 
the new formulation tested here, ACCS-B, did not statistically differ in its efficacy for 
treating experimental periodontal disease in rabbits from previously tested formulation, 
ACCS-U, it showed a clear potential in reducing bone loss during the progression of 
periodontitis. The results also reaffirm ACCS’s mechanism of action by stimulating 
hosts’ anti-inflammatory reactions, to achieve its goals. ACCS treated tissues showed 
significant reduction in both alveolar bone loss and inflammation in soft tissues. This was 
evident by the osteoclast-like cell counts, osteoblast-like cell counts, and inflammatory 
cell counts analyzed in TRAP stains, immunohistochemistry sections stained with 
oesteocalcin, and H&E slides respectively. In both groups of rabbits treated with ACCS-
U and ACCS-B, the number of osteoblast-like cells showed clear proliferation compared 
to other groups untreated, saline, and disease base groups, while the number of 
osteoclast-like cells and inflammatory cells showed clear reduction compared to rabbits 
in other groups. Osteoblasts are involved in alveolar bone growth whereas osteoclasts are 
involved in bone reabsorption. Therefore these results show that ACCS treated tissues 
demonstrate not only a reduction in bone loss and inflammation, but also a proliferation 
in bone gain. Although there was no clear statistical difference between two ACCS 
groups, this study supports the potential of using these ACCS formulations as a 
therapeutic intervention for one of the most prominent oral health diseases to date.  
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 In the field, there is a greater recognition of the need to suppress inflammatory 
response versus treatment of chronic periodontitis; however, no clear method was 
presented to reduce hosts’ inflammatory response. There is growing use of 
antihypertensive and immunosuppressant drugs to dampen the development of chronic 
periodontitis; however, none of the drugs evaluated to date -  anti-inflammatory steroids, 
non-steroidal drugs, anti-Tumor Necrosis Factor -alpha agents - have emerged as a 
potentially curative treatment for periodontal disease (Heasman et al, 2014). Moreover 
there is evidence that patients prescribed drugs to diminish development of gingival 
inflammation, such as bisphosphonates and anti-platelet drugs, are in great danger due to 
the risk of side effects. One of the side effects includes bisphosphonate-related 
osteonecrosis of the jaws (Janovská, 2012). With the NHANES report aforementioned 
describing patients with periodontal disease over 30 years old, the complications that 
drugs bring to treatment strategies puts serious pressure on patients. Furthermore, some 
of these drugs place patients at risk for more invasive dental procedures involving 
extractions and surgical treatments unlike ACCS treatments, which alleviates 
periodontitis while restoring damaged teeth and tissues to its original health (Heasman et 
al, 2014). With these reasons, increased effort and research in ACCS is required to treat 
periodontal disease as it is a far better treatment method than those previously attempted.  
 Periodontitis is often associated with other systematic inflammatory diseases. Pro-
inflammatory cytokines and other agents drive their pathogenesis in multidirectional 
matter eventually reaching other organs of the body notably, the heart, lungs, and the 
liver (El-Shinnawi et al, 2013). Moreover, due to the effect that periodontitis has on the 
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levels of proteins, cytokines, and other agents, it is possible that other diseases such as 
osteoporosis, cancer, diabetes, heart disease, and lung disease may stem from periodontal 
disease. This puts a greater emphasis on treating periodontitis, but it also shows that a 
body works as a whole; oral health does affect systemic health.  With its significant 
impact on controlling inflammation ACCS provides a potential for novel therapeutic 
approaches for periodontitis, but also for other inflammatory disease as well. 
Inflammatory diseases that involve bones, such as arthritis, can benefit potentially from 
ACCS’ as it may be useful in treating similar diseases by reducing inflammation as well 
as bone absorption. It is not simply limited to inflammatory diseases with bones but also 
to other inflammatory disease, because as this study illustrated, ACCS is capable of 
significantly reducing inflammatory response of the host by modulating cytokines and 
other agents. It is evident that ACCS has potential to shed light on discovering possible 
solutions to many inflammatory diseases still finding a cure today. Nonetheless, it will be 
very difficult to attempt to emulate the success of ACCS with periodontal disease in 
different parts of the body, due to vastly different environment that human body 
possesses. However, the findings of this study warrant the use of ACCS in further 
preclinical and clinical studies in periodontal disease and in other systemic inflammatory 
conditions. 
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